Carboplatin ototoxicity in retinoblastoma: Onset and monitoring

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 517-

  Shearer, Patricia ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PLATINUM DERIVATIVE;

AUDIOMETRY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE COURSE; EVIDENCE BASED PRACTICE; EVOKED AUDITORY RESPONSE; FOLLOW UP; HAIR CELL; HAIR DISEASE; HEARING LOSS; HUMAN; LETTER; LONG TERM CARE; MULTIPLE CYCLE TREATMENT; OTOACOUSTIC EMISSION; OTOTOXICITY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION; RETINOBLASTOMA; RISK; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHILD; EAR DISEASES; HUMANS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RETINOBLASTOMA;

EID: 67651211193     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22095     Document Type: Letter

References (5)

1. Jehanne M, Lumbroso-LeRouic L, Savignoni A, et al. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 2009;52:637-643.
2. Smits C, Swen SJ, Theo Goverts S, et al. Assessment of hearing in very young children receiving carboplatin for retinoblastoma. Eur J Cancer 2006;42:492-500. (Pubitemid 43227928)
3. Dean J, Hayashi SS, Albert CM, et al. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens. J Pediatr Hematol Oncol 2008;30:130-134.
4. Bertolini P, Lassalle M, Mercier G, et al. Platinum compound-related ototoxicity in children: Long term follow up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 2004;26:649-655. (Pubitemid 39350398)
5. Knight KR, Kraemer DF, Winter C, et al. Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 2007;25:1190-1195. (Pubitemid 46640564)